Javelin Biotech
PrivateLast Round
Grant
Jun 16, 2026
Total Funding Raised
$4.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Javelin Biotech is a biotechnology company that develops predictive drug discovery platforms merging human tissue chips with computational biology and machine learning to improve preclinical R&D productivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Javelin Biotech Comparables
Compare Javelin Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xellar Biosystems | 85% | |
| BiomimX | 82% | |
| Vivodyne | 82% |
Javelin Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Grant | Aug 30, 2023 | ||||
| Grant | Aug 18, 2022 | ||||
| Grant | Sep 21, 2021 | ||||
| Seed | Sep 3, 2019 |
Javelin Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shah Capital Partners | Seed |
| NIH RADx | Grant |
| Joyance Partners | Seed |
| InnoSpark Ventures | Seed |
| Social Starts | Seed |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 49% MoM, from 757 to 1.1K.
- May 15, 2026
Monthly visitors grew 208% MoM, reaching 1.9K.
Javelin Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Javelin Biotech's valuation, stock price, and market status.
Is Javelin Biotech a public or private company?
Javelin Biotech is a private company.
What is the current stock price of Javelin Biotech?
Javelin Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Javelin Biotech worth (valuation)?
Valuation information for Javelin Biotech is not publicly available.
Can I buy Javelin Biotech stock?
Javelin Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Javelin Biotech's last funding round?
Javelin Biotech's most recent funding round was Grant on June 16, 2026.
Who are the main investors in Javelin Biotech?
Key investors in Javelin Biotech include InnoSpark Ventures.
Will Javelin Biotech IPO soon?
No public IPO plans have been announced for Javelin Biotech.
How can I track Javelin Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Javelin Biotech's secondary market activity and sign up for updates.